Aldeyra Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your

Shareholders who purchased Aldeyra Therapeutics, Inc. (ALDX) shares during the class period from November 3, 2023 to March 16, 2026 may seek lead plaintiff status in a proposed securities-law violation lawsuit, according to a DJS Law Group press release. The deadline to appoint a lead plaintiff is May 29, 2026. Participation in the recovery does not require becoming lead plaintiff. The notice notes that the action is being led by DJS Law Group; the release may be considered attorney advertising in some jurisdictions. Investors were urged to contact DJS Law Group for more information about the case.